Weiss Multi-Strategy Advisers’s ChemoCentryx, Inc. CCXI Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-78,476	Closed	-$4.05M	–	812
2022 Q3	$4.05M	Buy	78,476 +68,471	+684%	+$2.83M	0.11%	277
2022 Q2	$248K	Buy	+10,005	New	+$221K	0.01%	602
2021 Q4	–	Sell	-25,000	Closed	-$428K	–	823
2021 Q3	$428K	Buy	+25,000	New	+$390K	0.01%	575
2014 Q1	–	Sell	-20,080	Closed	-$116K	–	1154
2013 Q4	$116K	Buy	+20,080	New	+$104K	﹤0.01%	932
2013 Q3	–	Sell	-45,000	Closed	-$636K	–	1026
2013 Q2	$636K	Buy	+45,000	New	+$583K	0.02%	439

Other funds holding CCXI

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Weiss Multi-Strategy Advisers's CCXI Position: Q4 2022 in Review

Weiss Multi-Strategy Advisers sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 78,476 shares — an estimated $4.05M sold.

Weiss Multi-Strategy Advisers first reported a position in CCXI in Q2 2013 and held it in 5 quarters. The position peaked at $4.05M in Q3 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

Weiss Multi-Strategy Advisers reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 78,476 ChemoCentryx, Inc. shares in Q4 2022, an estimated $4.05M.
Weiss Multi-Strategy Advisers first reported a position in ChemoCentryx, Inc. in Q2 2013 and held it in 5 quarters.
Weiss Multi-Strategy Advisers's ChemoCentryx, Inc. position peaked at $4.05M in Q3 2022.
1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q4 2022, filed 14 Feb 2023.